A rare disorder that disrupts the motion skills of infants and teenagers has been discovered thanks to a research collaboration involving a Cedars-Sinai pediatric neurologist. Dr. Tyler Pierson, PhD, joined with fellow scientists from nearly 50 institutions worldwide to report on 31 children with the condition, dubbed “HPDL deficiency.”
Cedars-Sinai Cancer has joined with precision medicine firm Tempus to design cancer treatment options that are increasingly personalized. The partnership harnesses artificial intelligence and big data to create virtual replicas of patients' DNA, RNA, protein and other information to help identify the most effective approach to overcoming each individual’s disease.
Sarah Vasen was a pioneering female physician who paved the way for women’s leadership at Cedars-Sinai. We asked some Cedars-Sinai physicians and leaders about her legacy and impact on women in medicine today.
Patients unable to undergo heart transplantation sometimes receive mechanical left ventricular assist devices to get the blood flowing properly—and otherwise healthy patients over age 75 should be provided the option more often.
A Cedars-Sinai study has found that IBD patients are not at increased risk of side effects from COVID-19 vaccines. The study also has revealed that more than 90% of IBD patients produced antibodies in response to COVID-19 vaccines.